Page last updated: 2024-08-23

alovudine and dactolisib

alovudine has been researched along with dactolisib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fuereder, T; Hejna, M; Hoeflmayer, D; Jaeger-Lansky, A; Kuntner, C; Langer, O; Müller, M; Pflegerl, P; Strommer, S; Wacheck, V; Wanek, T; Werzowa, J; Wrba, F	1

Other Studies

1 other study(ies) available for alovudine and dactolisib

Article	Year
Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Aug-15, Volume: 17, Issue:16 Topics: Animals; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Dose-Response Relationship, Drug; Female; Fluorine Radioisotopes; Humans; Imidazoles; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Quinolines; Radiopharmaceuticals; Signal Transduction; Stomach Neoplasms; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays	2011

Article

Year

Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Aug-15, Volume: 17, Issue:16

Topics: Animals; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Dose-Response Relationship, Drug; Female; Fluorine Radioisotopes; Humans; Imidazoles; Mice; Mice, Nude; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Quinolines; Radiopharmaceuticals; Signal Transduction; Stomach Neoplasms; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays

2011